Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update

NOVATO, Calif., April 25, 2024 -- Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultrarare...

Related Keywords

Carolyn Wang , Joshua Higa , Ultragenyx Pharmaceutical Inc , Nasdaq , , Markets ,